IMU Biosciences

London, United Kingdom

IMU is a discovery engine mapping the immune system to advance precision medicine.

$14.6M raised

Jan 2024

Series A

Biotechnology Health Care Life Science Precision Medicine

Top Investors

Molten VenturesLife Extension VenturesBeaumont Capital

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about IMU Biosciences

How much funding has IMU Biosciences raised?

IMU Biosciences has raised $14.6M in total funding. The most recent round was Series A. The last funding was announced in January 2024.

Who are IMU Biosciences's investors?

IMU Biosciences's investors include Molten Ventures, Life Extension Ventures, Beaumont Capital.

Where is IMU Biosciences headquartered?

IMU Biosciences is headquartered in London, United Kingdom.

What does IMU Biosciences do?

IMU is a discovery engine mapping the immune system to advance precision medicine.

What stage is IMU Biosciences at?

IMU Biosciences is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 24, 2024.

MLA

"IMU Biosciences — Funding & Investors." VCBacked, January 24, 2024, https://www.vcbacked.co/company/imu-biosciences. Accessed June 17, 2026.

APA

VCBacked. (2024). IMU Biosciences — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/imu-biosciences

Wikipedia (cite web)

{{cite web |title=IMU Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/imu-biosciences |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 24, 2024.

Similar Companies in Biotechnology